Keyphrases
Squamous Cell Carcinoma (SqCC)
100%
Sirtuin 1 (SIRT1)
66%
TERT Expression
66%
Head-and-neck Region
66%
Anogenital
66%
Expression Level
33%
Anatomical Location
33%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
33%
Tumor
33%
Papillomavirus Infections
33%
Cervix
33%
P53 Acetylation
33%
Combined Therapeutic
33%
In Cancer
33%
Chemotherapy
33%
Tumor Cells
33%
Oropharyngeal
33%
High Efficacy
33%
EX-527
33%
P53 Restoration
33%
Molecular Pathways
33%
Alternative Therapy
33%
Genotoxic Agents
33%
Cancer Cells
33%
Telomerase Inhibitor
33%
Therapeutic Intervention
33%
Patient Outcomes
33%
Neoplastic Cells
33%
Gene Editing
33%
Oropharynx Squamous Cell Carcinoma
33%
Aging
33%
Oncogenic Pathways
33%
Cas9 Protein
33%
Mucosal Epithelium
33%
Wild-type p53
33%
Telomerase Reverse Transcriptase Promoter
33%
Targeted Therapeutics
33%
Therapeutic Approaches
33%
Tumorigenesis
33%
Risk Factors
33%
Genital
33%
Dysregulated
33%
Alcohol Consumption
33%
High-risk Human Papillomavirus (HR-HPV)
33%
Activating mutation
33%
Specific mutation
33%
Small Molecules
33%
Radiotherapy
33%
Ionizing Radiation
33%
High-level Expression
33%
Medicine and Dentistry
Protein P53
100%
Squamous Cell Carcinoma
100%
Oropharynx Squamous Cell Carcinoma
66%
Neck
66%
Sirtuin1
66%
Carcinogenesis
66%
Clustered Regularly Interspaced Short Palindromic Repeat
33%
Papillomavirus Infection
33%
Cas9
33%
Side Effect
33%
Neoplasm
33%
Promoter Region
33%
Tumor Cell
33%
Alcohol Consumption
33%
Deacetylation
33%
Telomerase Inhibitor
33%
Upregulation
33%
Selisistat
33%
Cancer Cell
33%
Wart Virus
33%
Ionizing Radiation
33%
Uterine Cervix Carcinoma
33%
Telomerase Reverse Transcriptase
33%
Cancer
33%
Radiation Therapy
33%
Pharmacology, Toxicology and Pharmaceutical Science
Squamous Cell Carcinoma
100%
Protein P53
100%
Oropharynx Squamous Cell Carcinoma
66%
Neoplasm
66%
Carcinogenesis
66%
Malignant Neoplasm
33%
Telomerase Inhibitor
33%
Chemotherapy
33%
Selisistat
33%
Human Papillomavirus
33%
Telomerase Reverse Transcriptase
33%
Side Effect
33%
Papillomavirus Infection
33%
Uterine Cervix Carcinoma
33%
Ionizing Radiation
33%